Cas:100238-55-9 4-(2-chloroethoxy)phenol manufacturer & supplier

We serve Chemical Name:4-(2-chloroethoxy)phenol CAS:100238-55-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-(2-chloroethoxy)phenol

Chemical Name:4-(2-chloroethoxy)phenol
CAS.NO:100238-55-9
Synonyms:Phenol,4-(2-chloroethoxy)
Molecular Formula:C8H9ClO2
Molecular Weight:172.60900
HS Code:2909500000

Physical and Chemical Properties:
Melting point:N/A
Boiling point:301.819ºC at 760 mmHg
Density:1.235g/cm3
Index of Refraction:1.547
PSA:29.46000
Exact Mass:172.02900
LogP:2.00980

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Phenol,4-(2-chloroethoxy) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Phenol,4-(2-chloroethoxy) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Phenol,4-(2-chloroethoxy) Use and application,Phenol,4-(2-chloroethoxy) technical grade,usp/ep/jp grade.


Related News: US citizens who have been to China in the last 14 days need to re-book to one of seven gateway airports: John F. Kennedy International Airport in New York, Los Angeles International Airport, Seattle, San Francisco International Airport, Chicago, Atlanta and Honolulu. 4-(2-chloroethoxy)phenol manufacturer J&J, in a statement, confirmed that the FDA authorized the two batches, but did not acknowledge the doses regulators decided should be tossed. 4-(2-chloroethoxy)phenol supplier J&J, in a statement, confirmed that the FDA authorized the two batches, but did not acknowledge the doses regulators decided should be tossed. 4-(2-chloroethoxy)phenol vendor Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry. 4-(2-chloroethoxy)phenol factory Roche too has been riding high on the stock exchange this week, as investors still hope its more extensive Alzheimer’s profile could come good.